Showing results (71-80 of 279) with videos related to
Sort By:
Pageof 28
Investigational New Drugs|December 17, 2009
A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinomaChristopher W Ryan, Jacqueline Vuky, Joseph S Chan, et al.Anti-Cancer Drugs|December 18, 2009
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapyTomasz M Beer, Charles Ryan, Joshi Alumkal, et al.Journal of Oncology Practice|November 11, 2017
Management of Anticoagulation in Patients With Prostate Cancer Receiving EnzalutamideJoseph J Shatzel, Molly M Daughety, Sven R Olson, et al.International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancerS Christopher Hoffelt, Lynn M Marshall, Mark Garzotto, et al.Cancer|October 11, 2014
Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohortWon Jin Ho, Michael S Simon, Vedat O Yildiz, et al.Oncology|November 24, 2004
Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigenIrene Panagiotou, Tomasz M Beer, Yi-Ching Hsieh, et al.American Journal of Epidemiology|July 15, 2005
Statins and prostate cancer risk: a case-control studyJackilen Shannon, Selome Tewoderos, Mark Garzotto, et al.Science Letters Journal|April 15, 2016
Carbohydrate-conjugated fluorescent silica nanoprobes for selective detection of galectin-1 and prostate cancer cellsKe Jiang, Xin Wang, Hao Geng, et al.The Journal of Urology|February 14, 2006
Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsyStephen E F Spurgeon, Yi-Ching Hsieh, Adrianna Rivadinera, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind Javle, Gilbert N Lam, et al.Pageof 28